NCT06341842View on ClinicalTrials.gov

Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity

PHASE2RecruitingINTERVENTIONAL
Enrollment

316

Participants

Timeline

Start Date

October 19, 2023

Primary Completion Date

April 19, 2025

Study Completion Date

April 19, 2025

Conditions
Breast Cancer
Interventions
DRUG

Dapagliflozin 10mg Tab

Dapaglifloziin 10 mg 1 tab daily

Trial Locations (1)

27100

RECRUITING

Fondazione IRCCS Policlinico San Matteo, Pavia

All Listed Sponsors
lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER